Wed, Dec 24, 2014, 11:06 PM EST - U.S. Markets closed early today

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • superforce_57 superforce_57 May 17, 2013 12:06 PM Flag

    Is Zertane dead on arrival?

    ...2+ months since POPE approval & no deal. Not good.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This Zertane disappointment could cause big selling wave but let's hope not. The company should not be so secretive and sneeky. Investors don't like silence.

      • 2 Replies to racavalli
      • As Mark Twain would say, it would appear from the UBS conference that the rumors of the death of Zertane are a bit premature.

      • I certainly don't know what's going on, but I think that calling this a "Zertane disappointment" may be somewhat premature. Of course we all wanted to see an announcement of a deal on Zertane immediately following the POPE approval, and we all want to have weekly updates from the company on the status thereof. However, I am not that 'disappointed' that we haven't heard anything yet. these kinds of deals are not simple, and there is much posturing throughout, especially if there is the prospect of more than one player involved.

        With the company having already disclosed that they are in negotiations, it is incumbent upon them to advise of any change in that status - i.e.: no deal being negotiated any longer. Maybe the company is being "secretive and sneaky" as you say. However, I can understand the secrecy, and the sneakiness, to some extent, if it is in pursuit of the best deal possible and related to dealings with prospective acquirers/partners. If there is no deal then the company may have some issues with respect to being secretive and sneaky with investors/shareholders. that would be a whole different story.

        To this point, management has not done anything that would reflect deception as a typical course of dealing. That's not to say there is none, but it all comes out in the wash eventually, and management has not sold a single share of stock and is in the same boat as we are.

        If the drugs are good, the rewards will be there. Patience.

    • I don't know. My thoughts are that many may not be willing to pay the premiums asked until Phase III is completed.

 
AMPE
3.43+0.17(+5.21%)Dec 24 1:05 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.